+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 84Years
All Genders
Healthy Volunteers
ID07763418

Phase 1 Open-label Study of Golcadomide to Assess Pharmacokinetics and Safety in Adults With Severe Kidney Impairment and End-Stage Renal Disease Compared to Healthy Participants

Led by Bristol-Myers Squibb · Updated on 2026-10-01

30

Participants Needed

3

Research Sites

2 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the pharmacokinetics and safety of golcadomide BMS-986369 in different participant groups. These groups include healthy adults with normal kidney function, adults with severe renal impairment, and those with end-stage renal disease. The study aims to understand how the drug behaves in the body and its safety profile across these kidney function levels. Participants receive a single specified dose of golcadomide during the study. The study uses a parallel design with three groups healthy participants with normal renal function, participants with severe renal impairment, and participants with end-stage renal disease. Each group receives the drug and is monitored accordingly. Participants will undergo monitoring for up to 44 days to measure drug concentration levels in the blood, including maximum concentration, time to reach maximum concentration, and area under the plasma concentration-time curve. Safety evaluations, including physical exams, vital signs, ECGs, and laboratory tests, occur up to 44 or 60 days. Dialysate clearance of golcadomide is measured on Day 1. The total participation duration spans up to approximately two months.

CONDITIONS

Brief Title

A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function

Research Team

B

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com

F

First line of the email MUST contain NCT # and Site #.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here